Secondary acute angle closure attack as an initial presentation of a novel type of systemic lupus erythematosus
Background We report a rare case of secondary acute angle closure attack because of lupus choroidopathy and accompanying polyserositis, as an initial presentation of a novel type of systemic lupus erythematosus in a 44-year-old woman. Case presentation The patient complained of eyelid oedema and che...
Gespeichert in:
Veröffentlicht in: | Lupus 2019-11, Vol.28 (13), p.1594-1597 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1597 |
---|---|
container_issue | 13 |
container_start_page | 1594 |
container_title | Lupus |
container_volume | 28 |
creator | Sun, H -S Kong, X -Y Bai, Y -Y Li, M Hu, N -W |
description | Background
We report a rare case of secondary acute angle closure attack because of lupus choroidopathy and accompanying polyserositis, as an initial presentation of a novel type of systemic lupus erythematosus in a 44-year-old woman.
Case presentation
The patient complained of eyelid oedema and chemosis with bilateral severe loss of visual acuity. Systemic lupus erythematosus was diagnosed based on malar rash, polyserositis, proteinuria and positive antibody titers for antinuclear antibodies, anti-DNA, antinucleosome antibodies and ribosomal RNP. Subsequently, secondary bilateral acute angle closure caused by choroidal effusions with lupus choroidopathy was diagnosed. A month after steroid and immunosuppressive drug therapy, the patient’s intraocular pressure and visual acuity returned to normal. During the subsequent year, the secondary acute angle closure did not recur and polyserositis remained under control.
Conclusions
Bilateral, secondary acute angle closure attack due to SLE choroidopathy can be an initial presentation of SLE, which is often accompanied by polyserositis. Prompt and aggressive high doses of steroids and immunosuppressive therapy are strongly recommended. |
doi_str_mv | 10.1177/0961203319882764 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2307736070</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0961203319882764</sage_id><sourcerecordid>2307736070</sourcerecordid><originalsourceid>FETCH-LOGICAL-c431t-cd25a16b679cb67447e3946d420f82cb832fd3814e665b80c11285887d575e463</originalsourceid><addsrcrecordid>eNp1kctLxDAQxoMouj7uniTgxUs172SPsviCBQ_quWTT6dq1bWqSCvvfm2V9gOBlhpn5zZfwDUKnlFxSqvUVmSrKCOd0agzTSuygCRVaF7nPdtFkMy428wN0GOOKEJJJtY8OOFVcSqkmyD-B831lwxpbNybAtl-2gF3r4xhylZJ1b9jG3MdN36TGtngIEKFPNjW-x77GFvf-A1qc1gNs6riOCbrG4XYcxoghrNMrdDZlyXiM9mrbRjj5ykfo5fbmeXZfzB_vHmbX88IJTlPhKiYtVQulpy4HITTwqVCVYKQ2zC0MZ3XFDRWglFwY4ihlRhqjK6klCMWP0MVWdwj-fYSYyq6JDtrW9uDHWDJOtOaKaJLR8z_oyo-hz7_LFM3mai51psiWcsHHGKAuh9B02beSknJzjPLvMfLK2ZfwuOig-ln4dj8DxRaIdgm_r_4r-Amv7ZDc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2313317357</pqid></control><display><type>article</type><title>Secondary acute angle closure attack as an initial presentation of a novel type of systemic lupus erythematosus</title><source>MEDLINE</source><source>SAGE Complete</source><creator>Sun, H -S ; Kong, X -Y ; Bai, Y -Y ; Li, M ; Hu, N -W</creator><creatorcontrib>Sun, H -S ; Kong, X -Y ; Bai, Y -Y ; Li, M ; Hu, N -W</creatorcontrib><description>Background
We report a rare case of secondary acute angle closure attack because of lupus choroidopathy and accompanying polyserositis, as an initial presentation of a novel type of systemic lupus erythematosus in a 44-year-old woman.
Case presentation
The patient complained of eyelid oedema and chemosis with bilateral severe loss of visual acuity. Systemic lupus erythematosus was diagnosed based on malar rash, polyserositis, proteinuria and positive antibody titers for antinuclear antibodies, anti-DNA, antinucleosome antibodies and ribosomal RNP. Subsequently, secondary bilateral acute angle closure caused by choroidal effusions with lupus choroidopathy was diagnosed. A month after steroid and immunosuppressive drug therapy, the patient’s intraocular pressure and visual acuity returned to normal. During the subsequent year, the secondary acute angle closure did not recur and polyserositis remained under control.
Conclusions
Bilateral, secondary acute angle closure attack due to SLE choroidopathy can be an initial presentation of SLE, which is often accompanied by polyserositis. Prompt and aggressive high doses of steroids and immunosuppressive therapy are strongly recommended.</description><identifier>ISSN: 0961-2033</identifier><identifier>EISSN: 1477-0962</identifier><identifier>DOI: 10.1177/0961203319882764</identifier><identifier>PMID: 31635556</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Acuity ; Adult ; Anti-DNA antibodies ; Antinuclear antibodies ; Choroid Diseases - diagnosis ; Choroid Diseases - etiology ; Drug therapy ; Edema ; Eyelid ; Female ; Glaucoma, Angle-Closure - diagnosis ; Glaucoma, Angle-Closure - etiology ; Hardware reviews ; Humans ; Immunosuppressive agents ; Immunosuppressive Agents - administration & dosage ; LCDs ; Liquid crystal displays ; Lupus ; Lupus Erythematosus, Systemic - complications ; Lupus Erythematosus, Systemic - diagnosis ; Lupus Erythematosus, Systemic - drug therapy ; Polyserositis ; Proteinuria ; Steroid hormones ; Steroids - administration & dosage ; Systemic lupus erythematosus ; Visual Acuity</subject><ispartof>Lupus, 2019-11, Vol.28 (13), p.1594-1597</ispartof><rights>The Author(s) 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c431t-cd25a16b679cb67447e3946d420f82cb832fd3814e665b80c11285887d575e463</citedby><cites>FETCH-LOGICAL-c431t-cd25a16b679cb67447e3946d420f82cb832fd3814e665b80c11285887d575e463</cites><orcidid>0000-0001-7613-7271</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/0961203319882764$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/0961203319882764$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21798,27901,27902,43597,43598</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31635556$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sun, H -S</creatorcontrib><creatorcontrib>Kong, X -Y</creatorcontrib><creatorcontrib>Bai, Y -Y</creatorcontrib><creatorcontrib>Li, M</creatorcontrib><creatorcontrib>Hu, N -W</creatorcontrib><title>Secondary acute angle closure attack as an initial presentation of a novel type of systemic lupus erythematosus</title><title>Lupus</title><addtitle>Lupus</addtitle><description>Background
We report a rare case of secondary acute angle closure attack because of lupus choroidopathy and accompanying polyserositis, as an initial presentation of a novel type of systemic lupus erythematosus in a 44-year-old woman.
Case presentation
The patient complained of eyelid oedema and chemosis with bilateral severe loss of visual acuity. Systemic lupus erythematosus was diagnosed based on malar rash, polyserositis, proteinuria and positive antibody titers for antinuclear antibodies, anti-DNA, antinucleosome antibodies and ribosomal RNP. Subsequently, secondary bilateral acute angle closure caused by choroidal effusions with lupus choroidopathy was diagnosed. A month after steroid and immunosuppressive drug therapy, the patient’s intraocular pressure and visual acuity returned to normal. During the subsequent year, the secondary acute angle closure did not recur and polyserositis remained under control.
Conclusions
Bilateral, secondary acute angle closure attack due to SLE choroidopathy can be an initial presentation of SLE, which is often accompanied by polyserositis. Prompt and aggressive high doses of steroids and immunosuppressive therapy are strongly recommended.</description><subject>Acuity</subject><subject>Adult</subject><subject>Anti-DNA antibodies</subject><subject>Antinuclear antibodies</subject><subject>Choroid Diseases - diagnosis</subject><subject>Choroid Diseases - etiology</subject><subject>Drug therapy</subject><subject>Edema</subject><subject>Eyelid</subject><subject>Female</subject><subject>Glaucoma, Angle-Closure - diagnosis</subject><subject>Glaucoma, Angle-Closure - etiology</subject><subject>Hardware reviews</subject><subject>Humans</subject><subject>Immunosuppressive agents</subject><subject>Immunosuppressive Agents - administration & dosage</subject><subject>LCDs</subject><subject>Liquid crystal displays</subject><subject>Lupus</subject><subject>Lupus Erythematosus, Systemic - complications</subject><subject>Lupus Erythematosus, Systemic - diagnosis</subject><subject>Lupus Erythematosus, Systemic - drug therapy</subject><subject>Polyserositis</subject><subject>Proteinuria</subject><subject>Steroid hormones</subject><subject>Steroids - administration & dosage</subject><subject>Systemic lupus erythematosus</subject><subject>Visual Acuity</subject><issn>0961-2033</issn><issn>1477-0962</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kctLxDAQxoMouj7uniTgxUs172SPsviCBQ_quWTT6dq1bWqSCvvfm2V9gOBlhpn5zZfwDUKnlFxSqvUVmSrKCOd0agzTSuygCRVaF7nPdtFkMy428wN0GOOKEJJJtY8OOFVcSqkmyD-B831lwxpbNybAtl-2gF3r4xhylZJ1b9jG3MdN36TGtngIEKFPNjW-x77GFvf-A1qc1gNs6riOCbrG4XYcxoghrNMrdDZlyXiM9mrbRjj5ykfo5fbmeXZfzB_vHmbX88IJTlPhKiYtVQulpy4HITTwqVCVYKQ2zC0MZ3XFDRWglFwY4ihlRhqjK6klCMWP0MVWdwj-fYSYyq6JDtrW9uDHWDJOtOaKaJLR8z_oyo-hz7_LFM3mai51psiWcsHHGKAuh9B02beSknJzjPLvMfLK2ZfwuOig-ln4dj8DxRaIdgm_r_4r-Amv7ZDc</recordid><startdate>20191101</startdate><enddate>20191101</enddate><creator>Sun, H -S</creator><creator>Kong, X -Y</creator><creator>Bai, Y -Y</creator><creator>Li, M</creator><creator>Hu, N -W</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7613-7271</orcidid></search><sort><creationdate>20191101</creationdate><title>Secondary acute angle closure attack as an initial presentation of a novel type of systemic lupus erythematosus</title><author>Sun, H -S ; Kong, X -Y ; Bai, Y -Y ; Li, M ; Hu, N -W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c431t-cd25a16b679cb67447e3946d420f82cb832fd3814e665b80c11285887d575e463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Acuity</topic><topic>Adult</topic><topic>Anti-DNA antibodies</topic><topic>Antinuclear antibodies</topic><topic>Choroid Diseases - diagnosis</topic><topic>Choroid Diseases - etiology</topic><topic>Drug therapy</topic><topic>Edema</topic><topic>Eyelid</topic><topic>Female</topic><topic>Glaucoma, Angle-Closure - diagnosis</topic><topic>Glaucoma, Angle-Closure - etiology</topic><topic>Hardware reviews</topic><topic>Humans</topic><topic>Immunosuppressive agents</topic><topic>Immunosuppressive Agents - administration & dosage</topic><topic>LCDs</topic><topic>Liquid crystal displays</topic><topic>Lupus</topic><topic>Lupus Erythematosus, Systemic - complications</topic><topic>Lupus Erythematosus, Systemic - diagnosis</topic><topic>Lupus Erythematosus, Systemic - drug therapy</topic><topic>Polyserositis</topic><topic>Proteinuria</topic><topic>Steroid hormones</topic><topic>Steroids - administration & dosage</topic><topic>Systemic lupus erythematosus</topic><topic>Visual Acuity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sun, H -S</creatorcontrib><creatorcontrib>Kong, X -Y</creatorcontrib><creatorcontrib>Bai, Y -Y</creatorcontrib><creatorcontrib>Li, M</creatorcontrib><creatorcontrib>Hu, N -W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Lupus</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sun, H -S</au><au>Kong, X -Y</au><au>Bai, Y -Y</au><au>Li, M</au><au>Hu, N -W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Secondary acute angle closure attack as an initial presentation of a novel type of systemic lupus erythematosus</atitle><jtitle>Lupus</jtitle><addtitle>Lupus</addtitle><date>2019-11-01</date><risdate>2019</risdate><volume>28</volume><issue>13</issue><spage>1594</spage><epage>1597</epage><pages>1594-1597</pages><issn>0961-2033</issn><eissn>1477-0962</eissn><abstract>Background
We report a rare case of secondary acute angle closure attack because of lupus choroidopathy and accompanying polyserositis, as an initial presentation of a novel type of systemic lupus erythematosus in a 44-year-old woman.
Case presentation
The patient complained of eyelid oedema and chemosis with bilateral severe loss of visual acuity. Systemic lupus erythematosus was diagnosed based on malar rash, polyserositis, proteinuria and positive antibody titers for antinuclear antibodies, anti-DNA, antinucleosome antibodies and ribosomal RNP. Subsequently, secondary bilateral acute angle closure caused by choroidal effusions with lupus choroidopathy was diagnosed. A month after steroid and immunosuppressive drug therapy, the patient’s intraocular pressure and visual acuity returned to normal. During the subsequent year, the secondary acute angle closure did not recur and polyserositis remained under control.
Conclusions
Bilateral, secondary acute angle closure attack due to SLE choroidopathy can be an initial presentation of SLE, which is often accompanied by polyserositis. Prompt and aggressive high doses of steroids and immunosuppressive therapy are strongly recommended.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>31635556</pmid><doi>10.1177/0961203319882764</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0001-7613-7271</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0961-2033 |
ispartof | Lupus, 2019-11, Vol.28 (13), p.1594-1597 |
issn | 0961-2033 1477-0962 |
language | eng |
recordid | cdi_proquest_miscellaneous_2307736070 |
source | MEDLINE; SAGE Complete |
subjects | Acuity Adult Anti-DNA antibodies Antinuclear antibodies Choroid Diseases - diagnosis Choroid Diseases - etiology Drug therapy Edema Eyelid Female Glaucoma, Angle-Closure - diagnosis Glaucoma, Angle-Closure - etiology Hardware reviews Humans Immunosuppressive agents Immunosuppressive Agents - administration & dosage LCDs Liquid crystal displays Lupus Lupus Erythematosus, Systemic - complications Lupus Erythematosus, Systemic - diagnosis Lupus Erythematosus, Systemic - drug therapy Polyserositis Proteinuria Steroid hormones Steroids - administration & dosage Systemic lupus erythematosus Visual Acuity |
title | Secondary acute angle closure attack as an initial presentation of a novel type of systemic lupus erythematosus |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T04%3A24%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Secondary%20acute%20angle%20closure%20attack%20as%20an%20initial%20presentation%20of%20a%20novel%20type%20of%20systemic%20lupus%20erythematosus&rft.jtitle=Lupus&rft.au=Sun,%20H%20-S&rft.date=2019-11-01&rft.volume=28&rft.issue=13&rft.spage=1594&rft.epage=1597&rft.pages=1594-1597&rft.issn=0961-2033&rft.eissn=1477-0962&rft_id=info:doi/10.1177/0961203319882764&rft_dat=%3Cproquest_cross%3E2307736070%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2313317357&rft_id=info:pmid/31635556&rft_sage_id=10.1177_0961203319882764&rfr_iscdi=true |